Hostname: page-component-54dcc4c588-nx7b4 Total loading time: 0 Render date: 2025-10-12T19:54:12.140Z Has data issue: false hasContentIssue false
  • English
  • Français

Management of Subutex Addiction: A Case Report in a tunisian psychiatry unit

Published online by Cambridge University Press:  26 August 2025

A. Rami
A. Rami*
Affiliation:
Razi Hospital, Manouba, Tunisia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Subutex abuse in Tunisia is a phenomenon that is becoming more and more frequent and the management of which is not obvious due to the development of this substance in parallel markets.

Objectives

Our objective was to assess the patient’s Subutex use and initially assist with withdrawal, followed by achieving abstinence.

Methods

We followed the case of a patient in the psychiatric unit B at the Razi hospital, for depressive symptoms and having a problem of misuse of Subutex for 4 years, in a difficult family and social context.

Results

Patient follow-up was done over a one-year period with weekly consultation sessions at the beginning to assess the situation. Although withdrawal was done after a few weeks, it was essential to maintain this abstinence, using psychotherapy based on CBT done over 7 sessions.

During the study period, the patient violated abstinence only once in a family conflict.

Conclusions

The patient’s response to our management has reinforced the hope of being able to treat addiction to Subutex despite the severity of his condition and family and social instability.

Disclosure of Interest

None Declared

Information

Type
Abstract
Information
European Psychiatry , Volume 68 , Special Issue S1: Abstracts of the 33rd European Congress of Psychiatry , April 2025 , pp. S475
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.